Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2006 1
2007 1
2008 6
2009 5
2010 14
2011 17
2012 33
2013 66
2014 101
2015 141
2016 190
2017 274
2018 264
2019 318
2020 305
Text availability
Article attribute
Article type
Publication date

Search Results

1,561 results
Results by year
Filters applied: . Clear all
Page 1
Gut microbiome and type 2 diabetes: where we are and where to go?
Sharma S, Tripathi P. Sharma S, et al. J Nutr Biochem. 2019 Jan;63:101-108. doi: 10.1016/j.jnutbio.2018.10.003. Epub 2018 Oct 11. J Nutr Biochem. 2019. PMID: 30366260 Review.
Type 2 diabetes mellitus (T2D) is a highly prevalent metabolic disorder characterized by an imbalance in blood glucose level, altered lipid profile and high blood pressure. ...Any change in the gut microbiota can shift the host metabolism toward
Type 2 diabetes mellitus (T2D) is a highly prevalent metabolic disorder characterized by an imbalance in blood g
The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.
Brunkwall L, Orho-Melander M. Brunkwall L, et al. Diabetologia. 2017 Jun;60(6):943-951. doi: 10.1007/s00125-017-4278-3. Epub 2017 Apr 22. Diabetologia. 2017. PMID: 28434033 Free PMC article. Review.
During the last decade, evidence has accumulated to support a role for gut microbiota (analysed from faecal samples) in glycaemic control and type 2 diabetes. ...We discuss what is known about the composition and functionality of human gut microbiot
During the last decade, evidence has accumulated to support a role for gut microbiota (analysed from faecal samples) in glycaemic con …
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug.
Wu H, Esteve E, Tremaroli V, Khan MT, Caesar R, Mannerås-Holm L, Ståhlman M, Olsson LM, Serino M, Planas-Fèlix M, Xifra G, Mercader JM, Torrents D, Burcelin R, Ricart W, Perkins R, Fernàndez-Real JM, Bäckhed F. Wu H, et al. Nat Med. 2017 Jul;23(7):850-858. doi: 10.1038/nm.4345. Epub 2017 May 22. Nat Med. 2017. PMID: 28530702 Clinical Trial.
Metformin is widely used in the treatment of type 2 diabetes (T2D), but its mechanism of action is poorly defined. Recent evidence implicates the gut microbiota as a site of metformin action. ...Our findings provide support for the notion that altered …
Metformin is widely used in the treatment of type 2 diabetes (T2D), but its mechanism of action is poorly defined. Rece …
Type 2 diabetes and gut microbiome: at the intersection of known and unknown.
Upadhyaya S, Banerjee G. Upadhyaya S, et al. Gut Microbes. 2015;6(2):85-92. doi: 10.1080/19490976.2015.1024918. Gut Microbes. 2015. PMID: 25901889 Free PMC article. Review.
The contributing factors for type 2 diabetes range from genetic/epigenetic disposal, intra uterine nutrition, dietary pattern to sedentary lifestyle. The role of the gut microbiota in metabolic disorders is increasingly gaining importance. Several stud …
The contributing factors for type 2 diabetes range from genetic/epigenetic disposal, intra uterine nutrition, dietary p …
Gut microbiota and type 2 diabetes mellitus.
Muñoz-Garach A, Diaz-Perdigones C, Tinahones FJ. Muñoz-Garach A, et al. Endocrinol Nutr. 2016 Dec;63(10):560-568. doi: 10.1016/j.endonu.2016.07.008. Epub 2016 Sep 12. Endocrinol Nutr. 2016. PMID: 27633134 Review. English, Spanish.
In recent years, many studies have related gut microbiome to development of highly prevalent diseases such as type 2 diabetes and obesity. ...There are several mechanisms that relate microbiota to the onset of insulin resistance and diabetes
In recent years, many studies have related gut microbiome to development of highly prevalent diseases such as type 2
The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes.
Aydin Ö, Nieuwdorp M, Gerdes V. Aydin Ö, et al. Curr Diab Rep. 2018 Jun 21;18(8):55. doi: 10.1007/s11892-018-1020-6. Curr Diab Rep. 2018. PMID: 29931613 Free PMC article. Review.
PURPOSE OF REVIEW: The objective of this review is to critically assess the contributing role of the gut microbiota in human obesity and type 2 diabetes (T2D). RECENT FINDINGS: Experiments in animal and human studies have produced growing evidence for …
PURPOSE OF REVIEW: The objective of this review is to critically assess the contributing role of the gut microbiota in human obesity …
Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing.
Prattichizzo F, Giuliani A, Mensà E, Sabbatinelli J, De Nigris V, Rippo MR, La Sala L, Procopio AD, Olivieri F, Ceriello A. Prattichizzo F, et al. Ageing Res Rev. 2018 Dec;48:87-98. doi: 10.1016/j.arr.2018.10.003. Epub 2018 Oct 15. Ageing Res Rev. 2018. PMID: 30336272 Review.
Metformin is the first-choice therapy to lower glycaemia and manage type 2 diabetes. Continuously emerging epidemiological data and experimental models are showing additional protective effects of metformin against a number of age-related diseases (ARDs), e.g …
Metformin is the first-choice therapy to lower glycaemia and manage type 2 diabetes. Continuously emerging epidemiologi …
Precision nutrition for prevention and management of type 2 diabetes.
Wang DD, Hu FB. Wang DD, et al. Lancet Diabetes Endocrinol. 2018 May;6(5):416-426. doi: 10.1016/S2213-8587(18)30037-8. Epub 2018 Feb 9. Lancet Diabetes Endocrinol. 2018. PMID: 29433995 Review.
Recent advances in genomics, metabolomics, and gut microbiome technologies have offered opportunities as well as challenges in the use of precision nutrition to prevent and manage type 2 diabetes. ...By integrating these technologies with big data anal …
Recent advances in genomics, metabolomics, and gut microbiome technologies have offered opportunities as well as challenges in the us …
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, Prifti E, Vieira-Silva S, Gudmundsdottir V, Pedersen HK, Arumugam M, Kristiansen K, Voigt AY, Vestergaard H, Hercog R, Costea PI, Kultima JR, Li J, Jørgensen T, Levenez F, Dore J; MetaHIT consortium, Nielsen HB, Brunak S, Raes J, Hansen T, Wang J, Ehrlich SD, Bork P, Pedersen O. Forslund K, et al. Nature. 2015 Dec 10;528(7581):262-266. doi: 10.1038/nature15766. Epub 2015 Dec 2. Nature. 2015. PMID: 26633628 Free PMC article.
Our study addresses disease and drug signatures in the human gut microbiome of type 2 diabetes mellitus (T2D). Two previous quantitative gut metagenomics studies of T2D patients that were unstratified for treatment yielded divergent conclusions …
Our study addresses disease and drug signatures in the human gut microbiome of type 2 diabetes mellitus ( …
Insights into the role of the microbiome in obesity and type 2 diabetes.
Hartstra AV, Bouter KE, Bäckhed F, Nieuwdorp M. Hartstra AV, et al. Diabetes Care. 2015 Jan;38(1):159-65. doi: 10.2337/dc14-0769. Diabetes Care. 2015. PMID: 25538312 Review.
The worldwide prevalence of obesity and type 2 diabetes mellitus (T2DM) continues to rise at an alarming pace. Recently the potential role of the gut microbiome in these metabolic disorders has been identified. Obesity is associated with changes …
The worldwide prevalence of obesity and type 2 diabetes mellitus (T2DM) continues to rise at an alarming pace. R …
1,561 results
Jump to page
Feedback